About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The main characteristic of our group is its multidisciplinary nature, as it is comprised of neuroradiologists, technologists, and a physicist, engineer, and biochemist.
The main objectives of our projects are to gain knowledge about the pathophysiologic mechanisms implicated in several neurological diseases and to evaluate new biomarkers and therapies through the use of qualitative and quantitative magnetic resonance (MR) and computed tomography (CT) techniques, and by applying artificial intelligence tools to create prognostic models. Our focus is on the study of diseases such as multiple sclerosis, epilepsy, neuro-oncology, and stroke.
In addition, because of the experience we have acquired along the years in performing MR studies, we act as a platform for designing MR-based projects, processing images, and conducting quantitative data analysis.
The aim of the line is to evaluate the usefulness of MRI in the study of pituitary tumors, diagnosis and follow-up. The study focuses on the radiological characteristics of tumors that can predict their prognosis. Advances in neuroimaging and behavior of pituitary tumors specifically of macroadenomas are also evaluated, focusing on the radiological characteristics and their potential use with genetic and molecular markers, radiomic ACROFAST project which is a multicenter project.
IP: Silvana Isabel Sarria Estrada
The purpose is to investigate the effects of psychiatric disorders on brain structure, integrity and function.
IP: Alex Rovira Cañellas
The objective of this research line is to evaluate the structural changes that occur in the brain after or during epileptic seizures using different MRI techniques, as well as assess the role of MRI in the etiological diagnosis and location of the epileptogenic focus and analyze its influence on the treatment and evolution of these patients.
The aim of the line is to evaluate the added value of the information provided by MRI techniques, mainly aimed at the evaluation of melanin, myelin, presence of Fe, structural and functional connectivity in the study of Parkinson’s disease.
IP: Fco. Javier Aymerich Martínez, Alex Rovira Cañellas
The award recognizes his scientific career and his contribution to research and clinical care in multiple sclerosis.
Dr. Xavier Montalban, Dr. Álex Rovira, Dr. Mar Tintoré and Dr. Jaume Sastre Garriga have been recognised in the listing.
Her nomination means that she will represent UPF in the national competition held annually.
Magnetic Resonance image analysis
